What is the AI-Healthcare Industry?
Artificial Intelligence has become a key factor in the healthcare industry. The industry is increasingly being used for a range of solutions. For example, clinical decisions, where AI has the potential to deliver data-driven decisions, which help everything from genomics to radiology (imaging).
AI can also be used to improve compliance and reduce cost structures. Improve healthcare policy such as insurance. And finally, improve patient data access.

How we Rank these Ai-healthcare Investment Firms:
- Assets Under Management: The most prominent and active investors in the Ai-healthcare space.
- Units Under Management: How large are the investments, although this may vary by stage of investment.
- ROI/Success: How successful have these firms been when investing in AI-healthcare?
- Peer ranking: How well do the peers of these companies recognize their impact on AI-healthcare?
Are you a Company?

Are you an Investor or Fan?
AI-Healthcare
What is the AI-Healthcare industry?
Who are the top AI-Healthcare investors?
What is the market potential of the AI-Healthcare ?
What is the future of the AI-Healthcare?
What is trending in the AI-Healthcare?
What should you consider before you reach out to venture investors?
List of Top AI-Healthcare Investors

- Founded: 2001
- Headquarters: New York City, New York
- AUM: $3 billion+
RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. Their focus on investing across the various stages of investment, which they believe, gives them the flexibility to invest in quality AI-healthcare startups, such as Freenome, Frontier Medicine, and genetics company Antios Therapeutics. They recently invested in a Quantum Chemistry AI startup, New Equilibrium Bio. They have recently started focusing on Meta-health startups that they believe will drive the next round of healthcare innovation. They usually invest across different stages of investments and have been one of the most prominent AI and healthcare-focused investors on the scene.

- Founded: 2015
- Headquarters: Mountain View, California
- AUM: $1 billion+
Formerly known as Google Life Sciences, Verily is the healthcare venture arm of Google. Devoted to ‘life sciences’, it invests in early-stage and late-stage healthcare startups that seek to understand, detect, prevent and manage disease. They invested in a number of AI-focused projects including Freenome and Ondou. They have also invested in their own AI-focused R&D center in Israel. The company has no typical size of investments but invests across the healthcare sector, and looks to invest in the Series-A through D rounds of investments.

- Founded: 1996
- Headquarters: Boston, Massachusetts
- AUM: $4 billion
Polaris Partners is an investment firm that is focused on healthcare startups. They look to invest in healthcare companies across different stages of development. They have looked to deploy capital in numerous AI-healthcare startups, including the likes of Engine Bio-sciences, a drug discovery-focused AI-healthcare company. The companies they invest in are a mix of consumer and healthcare-focused. They have no typical size of investments but usually invest anywhere from $10-100 million in investments targeting the early to growth-stage investments. Their investments have been quite successful and numerous ones have gone onto IPO

- Founded: 2014
- Headquarters: Birmingham, United Kingdom
- AUM: $500 million+
Colcoron Ventures is a venture firm that is focused on investing in healthcare companies across various stages of development. They invest in Series-A through D and have backed numerous AI-focused firms. They have invested in the likes of Remedy, and various other AI drug delivery companies. Their focus is to invest in companies that are focused on compliance, delivery pathway drugs, and other solutions that work on supply chains for pharmaceuticals. Their focus is primarily on AI and healthcare and the intersection, which makes them an expert in the field. They usually invest anywhere from $5 to $20 million.

- Founded: 2015
- Headquarters: Beijing China/ San Francisco, California
- AUM: NA
Based out of Beijing and San Francisco, 3E bioventures is a healthcare-focused VC fund. China has been of particular focus for them due to the highly evolved AI ecosystem. But they have also looked to invest in U.S.-based healthcare/AI companies. Examples of prominent investments include Subtle Medical that is involved with AI-powered medical imaging. The venture fund invests across a range of stages from early-stage to later-stage, and has no typical size of investments. Their focus has been increasingly on the AI revolution coming out of China and will look to increasingly focus on the country for their future investments.

- Founded: 2002
- Headquarters: San Francisco, California
- AUM: $350 million
Based out of San Francisco, 5AM ventures is a healthcare-focused VC that invests in seed and early-stage capital. They have invested in a number of prominent AI-focused startups, including CAMP4, a RNA research startup.5AM’s partners believe AI is important to ensuring new drug discovery and ensuring a smooth compliance process within healthcare. The fund typically invests in the Series-A and B rounds of investments and the typical deal size vary around $1-20 million in investments.
AI-Healthcare Investors
What should you consider before you reach out to Ai Healthcare Venture Investors?
- Commercial Viability – does the product or service have utility and does it actually do what it says?
- Market Potential – can the product be commercialized and scaled?
- Unit Economics – does the product market sense in terms of its potential pricing power vs. underlying costs?
- Competition – is the product competitive and does it have reasonable competitive advantages to keep competition out?
- Product life cycle – how long will the product remain competitive and useful?

Are you Looking For the Top AI Focused Healthcare investors?

- Founded: 1999
- Headquarters: Copenhagen, Denmark
- AUM: $1 billion
Part of the Denmarks sovereign wealth fund, Novo Holding is a life-sciences-focused venture fund that looks to invest at a range of different stages. It recently invested in Qure.Ai, a leading imaging AI healthcare company. The company is looking to actively invest in next-generation healthcare in 2022. Novo Holdings focus on AI and healthcare, making them a prominent investor in the space and they have no typical size of investments. But they look to invest in both early-stage and latter-stage investments.

- Founded: 2005
- Headquarters: Kirkland, Washington
- AUM: $200 million+
Altitude life science is a venture capital firm that is based out of Kirkland, Washington. They look to invest in early-stage life science companies, with significant demand potential. The fund has invested in the likes of Biosymetrics, which looks to find solutions from large sets of medical data.

- Founded: 2017
- Headquarters: Pasadena, California
- AUM: $300 million+
Calibrate Ventures is a venture capital firm investing in early-revenue automation and AI companies. We partner with visionary founders bringing automation to diverse industries including education, healthcare, logistics, agriculture, financial services and beyond.

- Founded: 2008
- Headquarters: South Carolina
- AUM: $NA
Venture South is an angel network that looks to invest in seed and early-stage ventures. They are focused on startups in and around the Carolinas. They recently led the funding round in Gradient Health, which aims to improve and accelerate Ai diagnostics in medical imaging. While AI is not their primary focus, they are increasingly looking to deploy capital in the area.

- Founded: 1986
- Headquarters: Chicago, Illinois
- AUM: $2 billion+
Based out of Chicago, ARCH Venture Partners provides seed / early-stage venture capital for technology firms in information technology, life sciences, and physical sciences. The fund is looking to deploy capital into a number of different AI-focused ventures, including Biosymetrics, and Mobihealth.

- Founded: 2016
- Headquarters: Columbus, Georgia.
- AUM: $2 billion+
Aflac Ventures is an early-stage venture firm that seeks to invest in companies operating in cancer, health tech, insurtech, finance, internet of things, big data, and analytics sectors. The fund has invested across various stages of investment. Prominent investments include the likes of Sensely, an AI-based insurance startup.
What is the market potential of the AI-Healthcare ?


- Founded: 2017
- Headquarters: San Francisco California
- AUM: $100 mill
Based out of San Francisco, Joyance Partners, is a venture capital fund that invests in early stage health companies. They have a particular focus on genetics and biosciences. They have invested in companies such as inform.AI, which looks to improve patient delivery processes. They’re also looking to invest in neuroscience, and virtual/augmented reality focused startups.

- Founded: 2013
- Headquarters: Paris France
- AUM: $2 billion
Based out of Paris, France, BPI France is a venture capital fund, that is looking to target early-stage life-sciences companies. They fund companies from early-stage to late-stage and have invested in prominent names such as Owkin, which is AI platform access to data, while anonymizing patient datasets. They are also looking to deploy capital into AI focused DNA companies along with other forms of AI based healthcare.

- Founded: 2015
- Headquarters: San Francisco, California
- AUM: $600 million
Maverick venture is a venture capital startup, based in San Francisco. The fund focuses on early stage venture capital. Although it focuses on a range of industries, it has made some notable investments in the healthcare-AI space, such as Binah, which provides a healthcare monitoring platform.

- Founded: 2014
- Headquarters: San Francisco, California
- AUM: NA
iSeed Ventures is a micro- venture capital fund, that invests in, digital health, IoT, and consumer technology. With focus on early-stage venture capital, the company has made prominent investments across the healthcare space, including names such as Oncoro.
What is the future of the AI-Healthcare?
- According to researchers, AI and healthcare will continue to evolve dramatically over the coming years.
- The three main areas of focus will be: Patient, Clinician, and Administrative level AI. Improving productivity, outcomes and reducing bureaucracy are the biggest areas of focus.
- AI and healthcare will continue to attract an increasing capital as companies look to AI to solve everything from radiology to drug discovery using AI.
- Personalized medical treatments will increasingly become the norm.
- Big-data and analytics will continue to be a key part of the equation.

- Founded: 1989
- Headquarters: New York City, New York
- AUM: $2 billion
Based out of New York, OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics. They have invested in a number of early-stage companies, including ones in AI/healthcare. Prominent names include Zephry Med, which produces Ai-driven drug discovery.

- Founded: 2013
- Headquarters: San Francisco, California
- AUM: $1 billion
The fund concentrates largely on seed capital, but has been known to invest in early-stage ventures as well. It looks to back frontier technology and has invested in numerous AI-healthcare projects. Companies such as Kintsugi are examples of projects that it has backed.

- Founded: 2011
- Headquarters: New York City, New York
- AUM: $4 billion
Based out of New York, Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. They have recently started to invest in later stage rounds, and have made some prominent investments in startups such as Qventus. The firm has the capacity to deploy a range of capital, across the healthcare sector.

- Founded: 1961
- Headquarters: Palo Alto, California
- AUM: $12 billion
Part of Well Fargo, and based in Palo, Alto, Norwest Venture Partners is an American venture and growth equity investment firm with more than $12.5B in capital under management. The firm invests across industries, including the healthcare sector, and has recently looked towards AI as a key part of its portfolio. It has invested in numerous healthcare-AI startups and is looking to continue that trend in 2022.
AI-Healthcare

Are you Looking For the Top AI Focused Healthcare investors?
What is trending in the AI-Healthcare?
- Wearables, which make healthcare remote.
Wearables are a huge source of next generation tech that can be worth billions. Everything from tracking fertility, to ensuring cardiovascular health, blind-care and even detecting cancer will become part of the wearables/AI.
- Reducing human interactions and improving error rates in everything from radiology to immunotherapy.
Reducing human error, when looking at reports, is key to improving outcomes. AI is increasingly replacing humans in this area, where doctors are prone to error.
- Beyond that predictive outcomes are also a big area of focus, with firms increasingly looking to improve patient outcomes.
Clinical AI, that predicts outcomes will be a key source of healthcare. Predicting health issues is still a nascent industry, but key diseases are increasingly becoming an important part of healthcare.
- Data Collection, and Summary Dashboards are all big themes going into the year.
Big data and analytics are a key area that is likely to be funded, in 2022, as healthcare looks to ramp up improving compliance and outcomes. But Data can also be used by everyone from clinical studies to insurance companies to improve outcomes
- Robotics in healthcare.
Robotics is playing an increasingly important role, in ensuring that healthcare is automated especially for key surgeries.